Symbol="ENSC"
AssetType="Common Stock"
Name="Ensysce Biosciences Inc"
Description="Ensysce Biosciences, Inc., a clinical-stage biotechnology company, is dedicated to the development of various prescription drugs. The company is headquartered in La Jolla, California."
CIK="1716947"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="250 WEST 57TH ST., SUITE 415, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5262600"
EBITDA="-24221944"
PERatio="164.66"
PEGRatio="None"
BookValue="0.13"
DividendPerShare="0"
DividendYield="0"
EPS="-138.36"
RevenuePerShareTTM="6.53"
ProfitMargin="0"
OperatingMarginTTM="-8.11"
ReturnOnAssetsTTM="-1.687"
ReturnOnEquityTTM="-3288.95"
RevenueTTM="2709900"
GrossProfitTTM="-1158883"
DilutedEPSTTM="-128.05"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.309"
AnalystTargetPrice="14.39"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="1.947"
PriceToBookRatio="13.02"
EVToRevenue="-"
EVToEBITDA="-0.335"
Beta="0.531"
num_52WeekHigh="180"
num_52WeekLow="1.75"
num_50DayMovingAverage="2.146"
num_200DayMovingAverage="10.64"
SharesOutstanding="2769800"
DividendDate="None"
ExDividendDate="None"
symbol="ENSC"
open="1.93"
high="1.99"
low="1.88"
price="1.90"
volume="28402.00"
latest_trading_day="2023-08-04"
previous_close="1.95"
change="-0.05"
change_percent="-2.5641%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="766472"
Change_recent_avg="-0.07"
Delta_recent_avg="0.29"
Variance_recent_avg="0.14"
Change_ratio_recent_avg="-2.03"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="1101"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0134.jpeg"
image_negative_thumbnail_id_2="95"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_neutral_thumbnail_id_1="555"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_neutral_thumbnail_id_2="553"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_positive_thumbnail_id_1="993"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0155.jpeg"
image_positive_thumbnail_id_2="601"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0107.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
